Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Methamphetamine Use Disorder Untreated among Women in Methadone Treatment in Iran

Zahra Alammehrjerdi 1 , * , Nadine Ezard 2 , 3 , Philip Clare 4 and Kate Dolan 1
Authors Information
1 Program of International Research and Training, National Drug and Alcohol Research Centre, School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
2 Alcohol and Drug Service, St Vincent’s Hospital, Sydney, Australia
3 St Vincent’s Clinical School, University of New South Wales, Sydney, Australia
4 National Drug and Alcohol Research Centre, School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: June 2017, 11 (2); e7861
  • Published Online: November 22, 2016
  • Article Type: Original Article
  • Received: July 12, 2016
  • Revised: August 28, 2016
  • Accepted: November 4, 2016
  • DOI: 10.5812/ijpbs.7861

To Cite: Alammehrjerdi Z, Ezard N, Clare P, Dolan K. Methamphetamine Use Disorder Untreated among Women in Methadone Treatment in Iran, Iran J Psychiatry Behav Sci. 2017 ; 11(2):e7861. doi: 10.5812/ijpbs.7861.

Abstract
Copyright © 2016, Mazandaran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. United Nations Office on Drugs and Crime. World Drug Report. Vienna 2013;
  • 2. Nikfarjam A, Shokoohi M, Shahesmaeili A, Haghdoost AA, Baneshi MR, Haji-Maghsoudi S, et al. National population size estimation of illicit drug users through the network scale-up method in 2013 in Iran. Int J Drug Policy. 2016; 31: 147-52[DOI][PubMed]
  • 3. How to address methamphetamine involvement in OST settings. 2011;
  • 4. Lashkaripour K, Torbati E. Methamphetamine dependency. Int J High Risk Behav Addict. 2012; 1(1): 7-8[DOI]
  • 5. Taghizadeh H, Taghizadeh F, Fathi M, Reihani P, Shirdel N, Mohadesse Rezaee S. Drug use and high risk sexual behaviours of women at a drop in centre in Mazandaran province, Iran. Iran J Psychiatry Behav Sci. 2015; 9(2)[PubMed]
  • 6. Simpson JL, Grant KM, Daly PM, Kelley SG, Carlo G, Bevins RA. Psychological burden and gender differences in methamphetamine -dependent individuals in treatment. J Psychoactive Drugs. 2016; 48(4): 261-9[DOI][PubMed]
  • 7. Hser YL, Evans E, Huang YC. Treatment outcomes among men and women methamphetamine abusers in California. J Subst Abuse Treat. 2005; 28(1): 77-85[DOI][PubMed]
  • 8. Phillips KA, Epstein DH, Preston KL. Psychostimulant addiction treatment. Neuropharmacology. 2014; 87: 150-60[DOI][PubMed]
  • 9. Lee NK, Rawson RA. A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev. 2008; 27(3): 309-17[DOI][PubMed]
  • 10. Taymoori P, Pashaei T. Relapse and Risk-taking among Iranian Methamphetamine Abusers Undergoing Matrix Treatment Model. Addict Health. 2016; 8(1): 49-60[PubMed]
  • 11. Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict. 1992; 87(5): 593-602[PubMed]
  • 12. Sobell LC, Sobell MB, Buchan G, Cleland P, Fedoroff I, Leo G. The reliability of the Timeline Follow Back method applied to drug, cigarette, and cannabis use. . 1996;
  • 13. Khademi MJ, Monirpoor N. Validation of relapse timeline followback interview among Narcotics Anonymous clients. J Kermanshah Univ Med Sci. 2015; 19(4): 191-6
  • 14. Azizi A, Borjali A, Golzari M. The effectiveness of emotion regulation training and cognitive therapy on the emotional and addictional problems of substance abusers. Iran J Psychiatry. 2010; 5(2): 60-5[PubMed]
  • 15. Topp L, Mattick RP. Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction. 1997; 92(7): 839-45[PubMed]
  • 16. Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, et al. The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction. 1995; 90(5): 607-14[PubMed]
  • 17. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med. 1979; 9(1): 139-45[PubMed]
  • 18. Khosravi A, Mousavi SA, Chaman R, Sepidar Kish M, Ashrafi E, Khalili M. Reliability and validity of the Persian version of the World Health Organization-five well-being index. IJHS. 2015; 1(1): 17-9
  • 19. Biener L, Abrams DB. The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol. 1991; 10(5): 360-5[PubMed]
  • 20. Hogue A, Dauber S, Morgenstern J. Validation of a contemplation ladder in an adult substance use disorder sample. Psychol Addict Behav. 2010; 24(1): 137-44[DOI][PubMed]
  • 21. Amini-Lari M, Joulaei H, Faramarz H. Group cognitive-behavioural therapy for opiate use reduction in Shiraz: the first study from the Persian Gulf region of Iran. Int J High Risk Behavi Addict. 2016;
  • 22. Dolan K, Salimi S, Nassirimanesh B, Mohsenifar S, Allsop D, Mokri A. Six-month follow-up of Iranian women in methadone treatment: drug use, social functioning, crime, and HIV and HCV seroincidence. Subst Abuse Rehabil. 2012; 3: 37-43[DOI][PubMed]
  • 23. Dolan K, Salimi S, Nassirimanesh B, Mohsenifar S, Allsop D, Mokri A. Characteristics of Iranian women seeking drug treatment. J Womens Health (Larchmt). 2011; 20(11): 1687-91[DOI][PubMed]
  • 24. Alam-mehrjerdi Z, Daneshmand R, Samiei M, Samadi R, Abdollahi M, Dolan K. Women-only drug treatment services and needs in Iran: the first review of current literature. Daru. 2016; 24: 3[DOI][PubMed]
  • 25. Dluzen DE, Liu B. Gender differences in methamphetamine use and responses: a review. Gend Med. 2008; 5(1): 24-35[PubMed]
  • 26. Greenfield SF, Trucco EM, McHugh RK, Lincoln M, Gallop RJ. The Women's Recovery Group Study: a Stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling. Drug Alcohol Depend. 2007; 90(1): 39-47[DOI][PubMed]
  • 27. Forrest DW, Metsch LR, LaLota M, Cardenas G, Beck DW, Jeanty Y. Crystal methamphetamine use and sexual risk behaviors among HIV-positive and HIV-negative men who have sex with men in South Florida. J Urban Health. 2010; 87(3): 480-5[DOI][PubMed]
  • 28. Roshanfekr P, Noori R, Dejman M, Fathi-Geshnigani Z, Rafiey H. Drug use and sex work among at-risk women: a qualitative study of initial factors. Iran J Psychiatry Behav. 2015; 9(2)[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments